Today: 17 May 2026
Plug Power Stock Price Today: Shares Jump as New CEO Takes Turnaround Pitch to Investors
16 March 2026
1 min read

Plug Power Stock Price Today: Shares Jump as New CEO Takes Turnaround Pitch to Investors

NEW YORK, March 16, 2026, 12:48 EDT

Shares of Plug Power climbed 4.7% to $2.25 by midday Monday, following news that top executives plan to hold meetings with institutional investors in both Europe and Washington this week.

Plug’s cash pile is still a question mark, and that’s why these meetings count. On March 2, the company reported $368.5 million in unrestricted cash at the close of 2025. Plug also projected over $275 million coming in from planned asset sales connected to a big U.S. data-center expansion—money it said should keep operations funded into 2026.

Crespo stepped in as CEO on March 2, outlining Plug’s “clear priorities: disciplined execution, margin improvement, capital efficiency.” For the fourth quarter, the company swung to a positive gross margin—sales outpacing direct costs—after posting a negative margin the year before. Crespo added Plug would “continue executing with discipline” through this year. Plug Power

Conditions remain challenging. Plug’s 2025 revenue climbed to $709.9 million, up from $628.8 million the year before, according to Reuters data. Still, the company logged a net loss of $1.63 billion for the year.

Hydrogen and fuel-cell players lent a hand to Monday’s uptick. Ballard Power climbed 3.8%, and FuelCell Energy tacked on nearly 2.0%. Air Products, part of the industrial-gases sector, slipped.

Plug’s rebound doesn’t change the fact that the stock is still trading at about half its $4.58 52-week high, sitting just slightly above Friday’s $2.15 close. The gap underscores lingering wariness toward the shares.

Leadership staying the course is front and center here. After shifting from CEO to chairman this month, Andy Marsh told investors on March 3 he had “full confidence in his leadership,” with Plug sticking to its long-term profit targets under Crespo. Plug Power

The margin for error is tight. Plug burned through $535.8 million in operating cash in 2025. The company has flagged several risks: holding margins, wrapping up asset sales, keeping liquidity in check, locking down financing on terms it can live with, and shifts in clean-energy policy—all could throw off its strategy.

CFO Paul Middleton heads to London, Stockholm and Paris for a non-deal roadshow, with meetings running through March 18. These sessions aren’t linked to any equity offering. Over in Washington, Crespo and investor-relations chief Roberto Friedlander are slated to appear at JPMorgan’s Industrials Conference on Tuesday, the company confirmed.

Stock Market Today

  • S&P/TSX Composite Drops Over 400 Points Amid Inflation Fears and Rising Oil Prices
    May 17, 2026, 3:11 AM EDT. The S&P/TSX composite index fell 434.92 points to 33,833.35, weighed down by weaker precious metals and the materials sector. U.S. markets also declined with the Dow down 537.29 points, S&P 500 off 92.74 points, and Nasdaq down 410.08 points, led lower by tech and AI stocks. Rising global oil prices, driven by the Strait of Hormuz shutdown, plus fears of higher inflation, pushed bond yields up, with the 30-year U.S. Treasury yield returning to 2007 levels. Higher yields raise borrowing costs and pressure equities. The Bank of Canada is watching April inflation data closely amid energy price impacts. The Canadian dollar dipped to 72.72 US cents. Gold prices declined amid the market turbulence.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Dow Jones, S&P 500, Nasdaq Rise on Monday as Oil Falls Ahead of Fed, but Wall Street’s Rebound Looks Fragile
Previous Story

Dow Jones, S&P 500, Nasdaq Rise on Monday as Oil Falls Ahead of Fed, but Wall Street’s Rebound Looks Fragile

SoFi Technologies Stock Price Today: Why Shares Lagged Even as Fintech Stocks Climbed
Next Story

SoFi Technologies Stock Price Today: Why Shares Lagged Even as Fintech Stocks Climbed

Go toTop